跳至主要内容
临床试验/EUCTR2017-001011-36-FR
EUCTR2017-001011-36-FR进行中(未招募)1 期

Multicentric, comparative, randomized, open study comparing an early post-operative prophylactic non-invasive ventilation (NIV) to standard post-operative care in patients at high-risk of respiratory complications according to ARISCAT preoperative scoring system whose surgery is performed under general or loco-regional anesthesia (ANTICIPUSC).

INSTITUT DE CANCEROLOGIE DE L'OUEST0 个研究点目标入组 266 人开始时间: 2017年3月28日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
266

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 86
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 180

排除标准

  • 未提供

研究者

发起方
INSTITUT DE CANCEROLOGIE DE L'OUEST

相似试验

已完成
不适用
MULTICENTRIC, OPEN, RANDOMIZED, COMPARATIVE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TELITROMYCIN 800 MG VIA ORAL ONCE A DAY FOR 5 DAYS VS. AMOXICILLINE / CLAVULIC ACID 500/125 MG VIA ORAL THREE TIMES A DAY FOR 10 DAYS IN THE TREATMENT OF ACUTE MAXILAR SYNTHETIS OR MAXILAR-ACUTE ETHIOIDAL IN ADULTS.
PER-040-02AVENTIS PHARMA S.A.,
尚未招募
不适用
Study of efficacy and safety of Formair
CTRI/2017/01/007711Rus Biopharm150
进行中(未招募)
不适用
An open, randomised, comparative, multicentre study of the immunogenicity and safety of concomitant versus separate administration of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) and a booster dose of Infanrix® hexa in healthy children 12 to 23 months of age.
EUCTR2006-004129-27-DESanofi Pasteur MSD960
进行中(未招募)
不适用
An open, randomised, comparative, multicentre study of the immunogenicity and safety of M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX® when administered concomitantly by intramuscular (IM) route or subcutaneous (SC) route at two separate injection sites in healthy subjects 12 to 18 months of age - MMR rHA + VARIVAX IM or SC in 12-18 month-old healthy subjectsot applicable - Healthy subjects
EUCTR2004-002586-21-DEAventis Pasteur MSD SNC700
进行中(未招募)
不适用
Open, Randomised, Comparative, Multicentre Study of the Immunogenicity and Safety of Concomitant versus Separate administration of a combined measles, mumps, rubella and varicella live vaccine ProQuad and a Booster dose of Infanrix hexa in Healthy Children 12 to 23 months of age - X06-MMRV-302
EUCTR2006-004129-27-ITCASA MADRE960